Activation and Function of iNKT and MAIT Cells

Advances in Immunology

Volumn 127, Issue , 2015, Pages 145-201

  Chandra, Shilpi ^a   Kronenberg, Mitchell ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Glycolipid antigen; INKT and MAIT; Memory T cells; Microbial infection; T cell antigen receptor; Vitamin B metabolite

Indexed keywords

CD1D ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; DIACYLGLYCEROL; GAMMA INTERFERON; GLYCOSPHINGOLIPID; INOSITOL PHOSPHATE; INTERLEUKIN 17; NATURAL KILLER CELL RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; VITAMIN B GROUP;

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; BACTERIAL INFECTION; BORRELIA BURGDORFERI; BORRELIA INFECTION; CELL SURFACE; CYTOKINE PRODUCTION; EFFECTOR CELL; ENTAMOEBA HISTOLYTICA; GENE REARRANGEMENT; HELICOBACTER PYLORI; HERPES VIRUS INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA A; INNATE IMMUNITY; LEISHMANIASIS; MALARIA; MUCOSAL ASSOCIATED INVARIANT T CELL; MYCOSIS; NATURAL KILLER T CELL; NONHUMAN; PARASITOSIS; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; SPHINGOMONADACEAE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TISSUE DISTRIBUTION; TOXOPLASMOSIS; TUBERCULOSIS; VIRUS HEPATITIS; VIRUS INFECTION; ANIMAL; CYTOLOGY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MUCOSAL IMMUNITY; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD1D; HUMANS; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; LYMPHOCYTE ACTIVATION; NATURAL KILLER T-CELLS; T-LYMPHOCYTE SUBSETS;

EID: 84945482711     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/bs.ai.2015.03.003     Document Type: Chapter

References (275)

1. Alavi K.A. Amebiasis. Clinics in Colon and Rectal Surgery 2007, 20(1):33-37. 10.1055/s-2007-970198.
2. Albacker L.A., Chaudhary V., Chang Y.J., Kim H.Y., Chuang Y.T., Pichavant M., et al. Invariant natural killer T cells recognize a fungal glycosphingolipid that can induce airway hyperreactivity. Nature Medicine 2013, 19(10):1297-1304. 10.1038/nm.3321.
3. Albu D.I., VanValkenburgh J., Morin N., Califano D., Jenkins N.A., Copeland N.G., et al. Transcription factor Bcl11b controls selection of invariant natural killer T-cells by regulating glycolipid presentation in double-positive thymocytes. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(15):6211-6216. 10.1073/pnas.1014304108.
4. Aldemir H., Prod'homme V., Dumaurier M.J., Retiere C., Poupon G., Cazareth J., et al. Cutting edge: Lectin-like transcript 1 is a ligand for the CD161 receptor. Journal of Immunology 2005, 175(12):7791-7795.
5. Amano M., Baumgarth N., Dick M.D., Brossay L., Kronenberg M., Herzenberg L.A., et al. CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: Beta 2-microglobulin-dependent and independent forms. Journal of Immunology 1998, 161(4):1710-1717.
6. Amprey J.L., Im J.S., Turco S.J., Murray H.W., Illarionov P.A., Besra G.S., et al. A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. Journal of Experimental Medicine 2004, 200(7):895-904. 10.1084/jem.20040704.
7. An D., Oh S.F., Olszak T., Neves J.F., Avci F.Y., Erturk-Hasdemir D., et al. Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells. Cell 2014, 156(1-2):123-133. 10.1016/j.cell.2013.11.042.
8. Arase N., Arase H., Park S.Y., Ohno H., Ra C., Saito T. Association with FcRgamma is essential for activation signal through NKR-P1 (CD161) in natural killer (NK) cells and NK1.1+ T cells. Journal of Experimental Medicine 1997, 186(12):1957-1963.
9. Arase H., Arase N., Saito T. Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking. Journal of Experimental Medicine 1996, 183(5):2391-2396.
10. Asarnow D.M., Kuziel W.A., Bonyhadi M., Tigelaar R.E., Tucker P.W., Allison J.P. Limited diversity of gamma delta antigen receptor genes of Thy-1+ dendritic epidermal cells. Cell 1988, 55(5):837-847.
11. Banovic T., Yanilla M., Simmons R., Robertson I., Schroder W.A., Raffelt N.C., et al. Disseminated varicella infection caused by varicella vaccine strain in a child with low invariant natural killer T cells and diminished CD1d expression. Journal of Infectious Diseases 2011, 204(12):1893-1901. 10.1093/infdis/jir660.
12. Bedel R., Matsuda J.L., Brigl M., White J., Kappler J., Marrack P., et al. Lower TCR repertoire diversity in Traj18-deficient mice. Nature Immunology 2012, 13(8):705-706. 10.1038/ni.2347.
13. Behar S.M., Cardell S. Diverse CD1d-restricted T cells: Diverse phenotypes, and diverse functions. Seminars in Immunology 2000, 12(6):551-560. 10.1006/smim.2000.0273.
14. Bendelac A., Killeen N., Littman D.R., Schwartz R.H. A subset of CD4+ thymocytes selected by MHC class I molecules. Science 1994, 263(5154):1774-1778.
15. Bendelac A., Lantz O., Quimby M.E., Yewdell J.W., Bennink J.R., Brutkiewicz R.R. CD1 recognition by mouse NK1+ T lymphocytes. Science 1995, 268(5212):863-865.
16. Bendelac A., Savage P.B., Teyton L. The biology of NKT cells. Annual Review of Immunology 2007, 25:297-336. 10.1146/annurev.immunol.25.022106.141711.
17. Benlagha K., Kyin T., Beavis A., Teyton L., Bendelac A. A thymic precursor to the NK T cell lineage. Science 2002, 296(5567):553-555.
18. Benlagha K., Wei D.G., Veiga J., Teyton L., Bendelac A. Characterization of the early stages of thymic NKT cell development. Journal of Experimental Medicine 2005, 202(4):485-492. 10.1084/jem.20050456.
19. Benlagha K., Weiss A., Beavis A., Teyton L., Bendelac A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. Journal of Experimental Medicine 2000, 191(11):1895-1903.
20. Ben-Menachem G., Kubler-Kielb J., Coxon B., Yergey A., Schneerson R. A newly discovered cholesteryl galactoside from Borrelia burgdorferi. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(13):7913-7918. 10.1073/pnas.1232451100.
21. Berzins S.P., McNab F.W., Jones C.M., Smyth M.J., Godfrey D.I. Long-term retention of mature NK1.1+ NKT cells in the thymus. Journal of Immunology 2006, 176(7):4059-4065.
22. Billerbeck E., Kang Y.H., Walker L., Lockstone H., Grafmueller S., Fleming V., et al. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(7):3006-3011. 10.1073/pnas.0914839107.
23. Bleicher P.A., Balk S.P., Hagen S.J., Blumberg R.S., Flotte T.J., Terhorst C. Expression of murine CD1 on gastrointestinal epithelium. Science 1990, 250(4981):679-682.
24. Bourgeois E., Van L.P., Samson M., Diem S., Barra A., Roga S., et al. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. European Journal of Immunology 2009, 39(4):1046-1055. 10.1002/eji.200838575.
25. Brennan P.J., Brigl M., Brenner M.B. Invariant natural killer T cells: An innate activation scheme linked to diverse effector functions. Nature Reviews. Immunology 2013, 13(2):101-117. 10.1038/nri3369.
26. Brennan P.J., Tatituri R.V., Brigl M., Kim E.Y., Tuli A., Sanderson J.P., et al. Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nature Immunology 2011, 12(12):1202-1211. 10.1038/ni.2143.
27. Brennan P.J., Tatituri R.V., Heiss C., Watts G.F., Hsu F.F., Veerapen N., et al. Activation of iNKT cells by a distinct constituent of the endogenous glucosylceramide fraction. Proceedings of the National Academy of Sciences of the United States of America 2014, 111(37):13433-13438. 10.1073/pnas.1415357111.
28. Brigl M., Brenner M.B. CD1: Antigen presentation and T cell function. Annual Review of Immunology 2004, 22:817-890. 10.1146/annurev.immunol.22.012703.104608.
29. Brigl M., Bry L., Kent S.C., Gumperz J.E., Brenner M.B. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nature Immunology 2003, 4(12):1230-1237. 10.1038/ni1002.
30. Brigl M., Tatituri R.V., Watts G.F., Bhowruth V., Leadbetter E.A., Barton N., et al. Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. Journal of Experimental Medicine 2011, 208(6):1163-1177. 10.1084/jem.20102555.
31. Brigl M., van den Elzen P., Chen X., Meyers J.H., Wu D., Wong C.H., et al. Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors. Journal of Immunology 2006, 176(6):3625-3634.
32. Brodin P., Jojic V., Gao T., Bhattacharya S., Angel C.J., Furman D., et al. Variation in the human immune system is largely driven by non-heritable influences. Cell 2015, 160(1-2):37-47. 10.1016/j.cell.2014.12.020.
33. Brossay L., Jullien D., Cardell S., Sydora B.C., Burdin N., Modlin R.L., et al. Mouse CD1 is mainly expressed on hemopoietic-derived cells. Journal of Immunology 1997, 159(3):1216-1224.
34. Burdin N., Brossay L., Koezuka Y., Smiley S.T., Grusby M.J., Gui M., et al. Selective ability of mouse CD1 to present glycolipids: Alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. Journal of Immunology 1998, 161(7):3271-3281.
35. Burgdorfer W., Barbour A.G., Hayes S.F., Benach J.L., Grunwaldt E., Davis J.P. Lyme disease-a tick-borne spirochetosis?. Science 1982, 216(4552):1317-1319.
36. Cannons J.L., Yu L.J., Hill B., Mijares L.A., Dombroski D., Nichols K.E., et al. SAP regulates T(H)2 differentiation and PKC-theta-mediated activation of NF-kappaB1. Immunity 2004, 21(5):693-706. 10.1016/j.immuni.2004.09.012.
37. Cantu C., Benlagha K., Savage P.B., Bendelac A., Teyton L. The paradox of immune molecular recognition of alpha-galactosylceramide: Low affinity, low specificity for CD1d, high affinity for alpha beta TCRs. Journal of Immunology 2003, 170(9):4673-4682.
38. Cavallari M., Stallforth P., Kalinichenko A., Rathwell D.C., Gronewold T.M., Adibekian A., et al. A semisynthetic carbohydrate-lipid vaccine that protects against S. pneumoniae in mice. Nature Chemical Biology 2014, 10(11):950-956. 10.1038/nchembio.1650.
39. Cernadas M., Sugita M., van der Wel N., Cao X., Gumperz J.E., Maltsev S., et al. Lysosomal localization of murine CD1d mediated by AP-3 is necessary for NK T cell development. Journal of Immunology 2003, 171(8):4149-4155.
40. Chackerian A., Alt J., Perera V., Behar S.M. Activation of NKT cells protects mice from tuberculosis. Infection and Immunity 2002, 70(11):6302-6309.
41. Chang P.P., Barral P., Fitch J., Pratama A., Ma C.S., Kallies A., et al. Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses. Nature Immunology 2012, 13(1):35-43. 10.1038/ni.2166.
42. Chang C.C., Crane M., Zhou J., Mina M., Post J.J., Cameron B.A., et al. HIV and co-infections. Immunology Reviews 2013, 254(1):114-142. 10.1111/imr.12063.
43. Chang Y.J., Kim H.Y., Albacker L.A., Lee H.H., Baumgarth N., Akira S., et al. Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity. Journal of Clinical Investigation 2011, 121(1):57-69. 10.1172/JCI44845.
44. Chaudhary V., Albacker L.A., Deng S., Chuang Y.T., Li Y., Umetsu D.T., et al. Synthesis of fungal glycolipid asperamide B and investigation of its ability to stimulate natural killer T cells. Organic Letters 2013, 15(20):5242-5245. 10.1021/ol4024375.
45. Cheroutre H., Lambolez F., Mucida D. The light and dark sides of intestinal intraepithelial lymphocytes. Nature Reviews. Immunology 2011, 11(7):445-456. 10.1038/nri3007.
46. Chiu Y.H., Jayawardena J., Weiss A., Lee D., Park S.H., Dautry-Varsat A., et al. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. Journal of Experimental Medicine 1999, 189(1):103-110.
47. Chiu Y.H., Park S.H., Benlagha K., Forestier C., Jayawardena-Wolf J., Savage P.B., et al. Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d. Nature Immunology 2002, 3(1):55-60. 10.1038/ni740.
48. Christiansen D., Milland J., Mouhtouris E., Vaughan H., Pellicci D.G., McConville M.J., et al. Humans lack iGb3 due to the absence of functional iGb3-synthase: Implications for NKT cell development and transplantation. PLoS Biology 2008, 6(7):e172. 10.1371/journal.pbio.0060172.
49. Chua W.J., Truscott S.M., Eickhoff C.S., Blazevic A., Hoft D.F., Hansen T.H. Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection. Infection and Immunity 2012, 80(9):3256-3267. IAI.00279-12 [pii]. 10.1128/IAI.00279-12.
50. Chung B., Aoukaty A., Dutz J., Terhorst C., Tan R. Signaling lymphocytic activation molecule-associated protein controls NKT cell functions. Journal of Immunology 2005, 174(6):3153-3157.
51. Cohen N.R., Garg S., Brenner M.B. Antigen presentation by CD1 lipids, T cells, and NKT cells in microbial immunity. Advances in Immunology 2009, 102:1-94. 10.1016/S0065-2776(09)01201-2.
52. Cohen N.R., Tatituri R.V., Rivera A., Watts G.F., Kim E.Y., Chiba A., et al. Innate recognition of cell wall beta-glucans drives invariant natural killer T cell responses against fungi. Cell Host & Microbe 2011, 10(5):437-450. 10.1016/j.chom.2011.09.011.
53. Coles M.C., Raulet D.H. NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells. Journal of Immunology 2000, 164(5):2412-2418.
54. Corbett A.J., Eckle S.B., Birkinshaw R.W., Liu L., Patel O., Mahony J., et al. T-cell activation by transitory neo-antigens derived from distinct microbial pathways. Nature 2014, 509(7500):361-365. 10.1038/nature13160.
55. Cornish A.L., Keating R., Kyparissoudis K., Smyth M.J., Carbone F.R., Godfrey D.I. NKT cells are not critical for HSV-1 disease resolution. Immunology and Cell Biology 2006, 84(1):13-19. 10.1111/j.1440-1711.2005.01396.x.
56. Cosgrove C., Ussher J.E., Rauch A., Gartner K., Kurioka A., Huhn M.H., et al. Early and nonreversible decrease of CD161(++)/MAIT cells in HIV infection. Blood 2013, 121(6):951-961. 10.1182/Blood-2012-06-436436.
57. Cox D., Fox L., Tian R., Bardet W., Skaley M., Mojsilovic D., et al. Determination of cellular lipids bound to human CD1d molecules. PLoS One 2009, 4(5):e5325. 10.1371/journal.pone.0005325.
58. Cui J., Shin T., Kawano T., Sato H., Kondo E., Toura I., et al. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 1997, 278(5343):1623-1626.
59. Dashtsoodol N., Watarai H., Sakata S., Taniguchi M. Identification of CD4(-)CD8(-) double-negative natural killer T cell precursors in the thymus. PLoS One 2008, 3(11):e3688. 10.1371/journal.pone.0003688.
60. D'Cruz L.M., Knell J., Fujimoto J.K., Goldrath A.W. An essential role for the transcription factor HEB in thymocyte survival, Tcra rearrangement and the development of natural killer T cells. Nature Immunology 2010, 11(3):240-249. 10.1038/ni.1845.
61. De Santo C., Salio M., Masri S.H., Lee L.Y., Dong T., Speak A.O., et al. Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. Journal of Clinical Investigation 2008, 118(12):4036-4048. 10.1172/JCI36264.
62. Dellabona P., Casorati G., Friedli B., Angman L., Sallusto F., Tunnacliffe A., et al. In vivo persistence of expanded clones specific for bacterial antigens within the human T cell receptor alpha/beta CD4-8- subset. Journal of Experimental Medicine 1993, 177(6):1763-1771.
63. Dellabona P., Padovan E., Casorati G., Brockhaus M., Lanzavecchia A. An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells. Journal of Experimental Medicine 1994, 180(3):1171-1176.
64. Doisne J.M., Becourt C., Amniai L., Duarte N., Le Luduec J.B., Eberl G., et al. Skin and peripheral lymph node invariant NKT cells are mainly retinoic acid receptor-related orphan receptor (gamma)t+ and respond preferentially under inflammatory conditions. Journal of Immunology 2009, 183(3):2142-2149. 10.4049/jimmunol.0901059.
65. Dong Z., Zhang C., Wei H., Sun R., Tian Z. Impaired NK cell cytotoxicity by high level of interferon-gamma in concanavalin A-induced hepatitis. Canadian Journal of Physiology and Pharmacology 2005, 83(11):1045-1053. 10.1139/y05-093.
66. Dusseaux M., Martin E., Serriari N., Peguillet I., Premel V., Louis D., et al. Human MAIT cells are xenobiotic resistant, tissue-targeted, CD161hi IL-17 secreting T cells. Blood 2010, blood-2010-08-303339 [pii]. 10.1182/blood-2010-08-303339.
67. Eagle R.A., Jafferji I., Barrow A.D. Beyond stressed self: Evidence for NKG2D ligand expression on healthy cells. Current Immunology Reviews 2009, 5(1):22-34. 10.2174/157339509787314369.
68. Eberl G., Lowin-Kropf B., MacDonald H.R. Cutting edge: NKT cell development is selectively impaired in Fyn-deficient mice. Journal of Immunology 1999, 163(8):4091-4094.
69. Eckle S.B., Birkinshaw R.W., Kostenko L., Corbett A.J., McWilliam H.E., Reantragoon R., et al. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells. Journal of Experimental Medicine 2014, 211(8):1585-1600. 10.1084/jem.20140484.
70. Elewaut D., Lawton A.P., Nagarajan N.A., Maverakis E., Khurana A., Honing S., et al. The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Valpha14i NKT cells. Journal of Experimental Medicine 2003, 198(8):1133-1146. 10.1084/jem.20030143.
71. Enders A., Stankovic S., Teh C., Uldrich A.P., Yabas M., Juelich T., et al. ZBTB7B (Th-POK) regulates the development of IL-17-producing CD1d-restricted mouse NKT cells. Journal of Immunology 2012, 189(11):5240-5249. 10.4049/jimmunol.1201486.
72. Engel I., Hammond K., Sullivan B.A., He X., Taniuchi I., Kappes D., et al. Co-receptor choice by V alpha14i NKT cells is driven by Th-POK expression rather than avoidance of CD8-mediated negative selection. Journal of Experimental Medicine 2010, 207(5):1015-1029. 10.1084/jem.20090557.
73. Engel I., Kronenberg M. Making memory at birth: Understanding the differentiation of natural killer T cells. Current Opinion in Immunology 2012, 24(2):184-190. 10.1016/j.coi.2012.01.012.
74. Engel I., Zhao M., Kappes D., Taniuchi I., Kronenberg M. The transcription factor Th-POK negatively regulates Th17 differentiation in Valpha14i NKT cells. Blood 2012, 120(23):4524-4532. 10.1182/blood-2012-01-406280.
75. Exley M., Porcelli S., Furman M., Garcia J., Balk S. CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24 J alpha Q T cell receptor alpha chains. Journal of Experimental Medicine 1998, 188(5):867-876.
76. Facciotti F., Ramanjaneyulu G.S., Lepore M., Sansano S., Cavallari M., Kistowska M., et al. Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus. Nature Immunology 2012, 13(5):474-480. 10.1038/ni.2245.
77. Forestier C., Park S.H., Wei D., Benlagha K., Teyton L., Bendelac A. T cell development in mice expressing CD1d directed by a classical MHC class II promoter. Journal of Immunology 2003, 171(8):4096-4104.
78. Gadola S.D., Dulphy N., Salio M., Cerundolo V. Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes. Journal of Immunology 2002, 168(11):5514-5520.
79. Gadola S.D., Silk J.D., Jeans A., Illarionov P.A., Salio M., Besra G.S., et al. Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. Journal of Experimental Medicine 2006, 203(10):2293-2303. 10.1084/jem.20060921.
80. Gapin L., Godfrey D.I., Rossjohn J. Natural killer T cell obsession with self-antigens. Current Opinion in Immunology 2013, 25(2):168-173. 10.1016/j.coi.2013.01.002.
81. Gapin L., Matsuda J.L., Surh C.D., Kronenberg M. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nature Immunology 2001, 2(10):971-978. 10.1038/ni710.
82. Gasser S., Orsulic S., Brown E.J., Raulet D.H. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005, 436(7054):1186-1190. 10.1038/nature03884.
83. Geissmann F., Cameron T.O., Sidobre S., Manlongat N., Kronenberg M., Briskin M.J., et al. Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biology 2005, 3(4):e113. 10.1371/journal.pbio.0030113.
84. Georgel P., Radosavljevic M., Macquin C., Bahram S. The non-conventional MHC class I MR1 molecule controls infection by Klebsiella pneumoniae in mice. Molecular Immunology 2011, 48(5):769-775. 10.1016/j.molimm.2010.12.002.
85. Gilleron M., Ronet C., Mempel M., Monsarrat B., Gachelin G., Puzo G. Acylation state of the phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette Guerin and ability to induce granuloma and recruit natural killer T cells. Journal of Biological Chemistry 2001, 276(37):34896-34904. 10.1074/jbc.M103908200.
86. Girardi E., Yu E.D., Li Y., Tarumoto N., Pei B., Wang J., et al. Unique interplay between sugar and lipid in determining the antigenic potency of bacterial antigens for NKT cells. PLoS Biology 2011, 9(11):e1001189. 10.1371/journal.pbio.1001189.
87. Girardi E., Zajonc D.M. Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells. Immunology Reviews 2012, 250(1):167-179. 10.1111/j.1600-065X.2012.01166.x.
88. Godfrey D.I., MacDonald H.R., Kronenberg M., Smyth M.J., Van Kaer L. NKT cells: What's in a name?. Nature Reviews. Immunology 2004, 4(3):231-237. 10.1038/nri1309.
89. Gold M.C., Cerri S., Smyk-Pearson S., Cansler M.E., Vogt T.M., Delepine J., et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biology 2010, 8(6):e1000407. 10.1371/journal.pbio.1000407.
90. Gold M.C., McLaren J.E., Reistetter J.A., Smyk-Pearson S., Ladell K., Swarbrick G.M., et al. MR1-restricted MAIT cells display ligand discrimination and pathogen selectivity through distinct T cell receptor usage. Journal of Experimental Medicine 2014, 211(8):1601-1610. 10.1084/Jem.20140507.
91. Gonzalez-Aseguinolaza G., de Oliveira C., Tomaska M., Hong S., Bruna-Romero O., Nakayama T., et al. alpha-Galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. Proceedings of the National Academy of Sciences of the United States of America 2000, 97(15):8461-8466.
92. Govan J.R., Deretic V. Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiological Reviews 1996, 60(3):539-574.
93. Griewank K., Borowski C., Rietdijk S., Wang N., Julien A., Wei D.G., et al. Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity 2007, 27(5):751-762. 10.1016/j.immuni.2007.08.020.
94. Grubor-Bauk B., Arthur J.L., Mayrhofer G. Importance of NKT cells in resistance to herpes simplex virus, fate of virus-infected neurons, and level of latency in mice. Journal of Virology 2008, 82(22):11073-11083. 10.1128/JVI.00205-08.
95. Grubor-Bauk B., Simmons A., Mayrhofer G., Speck P.G. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR. Journal of Immunology 2003, 170(3):1430-1434.
96. Guo J., Hawwari A., Li H., Sun Z., Mahanta S.K., Littman D.R., et al. Regulation of the TCRalpha repertoire by the survival window of CD4(+)CD8(+) thymocytes. Nature Immunology 2002, 3(5):469-476. 10.1038/ni791.
97. Hager E., Hawwari A., Matsuda J.L., Krangel M.S., Gapin L. Multiple constraints at the level of TCRalpha rearrangement impact Valpha14i NKT cell development. Journal of Immunology 2007, 179(4):2228-2234.
98. Hansen D.S., Siomos M.A., Buckingham L., Scalzo A.A., Schofield L. Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex. Immunity 2003, 18(3):391-402.
99. Harker K.S., Ueno N., Lodoen M.B. Toxoplasma gondii dissemination: A parasite's journey through the infected host. Parasite Immunology 2015, 37(3):141-149. 10.1111/pim.12163.
100. Ho L.P., Denney L., Luhn K., Teoh D., Clelland C., McMichael A.J. Activation of invariant NKT cells enhances the innate immune response and improves the disease course in influenza A virus infection. European Journal of Immunology 2008, 38(7):1913-1922. 10.1002/eji.200738017.
101. Hofhuis A., Harms M., Bennema S., van den Wijngaard C.C., van Pelt W. Physician reported incidence of early and late Lyme borreliosis. Parasites and Vectors 2015, 8(1):777. 10.1186/s13071-015-0777-6.
102. Holzapfel K.L., Tyznik A.J., Kronenberg M., Hogquist K.A. Antigen-dependent versus -independent activation of invariant NKT cells during infection. Journal of Immunology 2014, 192(12):5490-5498. 10.4049/jimmunol.1400722.
103. Hsueh P.R., Teng L.J., Yang P.C., Chen Y.C., Pan H.J., Ho S.W., et al. Nosocomial infections caused by Sphingomonas paucimobilis: Clinical features and microbiological characteristics. Clinical Infectious Diseases 1998, 26(3):676-681.
104. Hu T., Simmons A., Yuan J., Bender T.P., Alberola-Ila J. The transcription factor c-Myb primes CD4+CD8+ immature thymocytes for selection into the iNKT lineage. Nature Immunology 2010, 11(5):435-441. 10.1038/ni.1865.
105. Huang S., Gilfillan S., Kim S., Thompson B., Wang X., Sant A.J., et al. MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells. Journal of Experimental Medicine 2008, 205(5):1201-1211. jem.20072579 [pii]. 10.1084/jem.20072579.
106. Huang S., Martin E., Kim S., Yu L., Soudais C., Fremont D.H., et al. MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(20):8290-8295. 0903196106 [pii]. 10.1073/pnas.0903196106.
107. Ito Y., Vela J.L., Matsumura F., Hoshino H., Tyznik A., Lee H., et al. Helicobacter pylori cholesteryl alpha-glucosides contribute to its pathogenicity and immune response by natural killer T cells. PLoS One 2013, 8(12):e78191. 10.1371/journal.pone.0078191.
108. Itohara S., Farr A.G., Lafaille J.J., Bonneville M., Takagaki Y., Haas W., et al. Homing of a gamma delta thymocyte subset with homogeneous T-cell receptors to mucosal epithelia. Nature 1990, 343(6260):754-757. 10.1038/343754a0.
109. Jayawardena-Wolf J., Benlagha K., Chiu Y.H., Mehr R., Bendelac A. CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 2001, 15(6):897-908.
110. Joyee A.G., Uzonna J., Yang X. Invariant NKT cells preferentially modulate the function of CD8 alpha+ dendritic cell subset in inducing type 1 immunity against infection. Journal of Immunology 2010, 184(4):2095-2106. 10.4049/jimmunol.0901348.
111. Juno J.A., Keynan Y., Fowke K.R. Invariant NKT cells: Regulation and function during viral infection. PLoS Pathogen 2012, 8(8):e1002838. 10.1371/journal.ppat.1002838.
112. Kageyama R., Cannons J.L., Zhao F., Yusuf I., Lao C., Locci M., et al. The receptor Ly108 functions as a SAP adaptor-dependent on-off switch for T cell help to B cells and NKT cell development. Immunity 2012, 36(6):986-1002. 10.1016/j.immuni.2012.05.016.
113. Kain L., Webb B., Anderson B.L., Deng S., Holt M., Costanzo A., et al. The identification of the endogenous ligands of natural killer T cells reveals the presence of mammalian alpha-linked glycosylceramides. Immunity 2014, 41(4):543-554. 10.1016/j.immuni.2014.08.017.
114. Kakimi K., Guidotti L.G., Koezuka Y., Chisari F.V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. Journal of Experimental Medicine 2000, 192(7):921-930.
115. Kampfer P., Witzenberger R., Denner E.B., Busse H.J., Neef A. Sphingopyxis witflariensis sp. nov., isolated from activated sludge. International Journal of Systematic and Evolutionary Microbiology 2002, 52(Pt 6):2029-2034.
116. Kappes D.J. Expanding roles for ThPOK in thymic development. Immunology Reviews 2010, 238(1):182-194. 10.1111/j.1600-065X.2010.00958.x.
117. Karmakar S., Bhaumik S.K., Paul J., De T. TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis. PLoS Pathogen 2012, 8(4):e1002646. 10.1371/journal.ppat.1002646.
118. Kawachi I., Maldonado J., Strader C., Gilfillan S. MR1-restricted V alpha 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response. Journal of Immunology 2006, 176(3):1618-1627.
119. Kawahara K., Kubota M., Sato N., Tsuge K., Seto Y. Occurrence of an alpha-galacturonosyl-ceramide in the dioxin-degrading bacterium Sphingomonas wittichii. FEMS Microbiology Letters 2002, 214(2):289-294.
120. Kawahara K., Moll H., Knirel Y.A., Seydel U., Zahringer U. Structural analysis of two glycosphingolipids from the lipopolysaccharide-lacking bacterium Sphingomonas capsulata. European Journal of Biochemistry 2000, 267(6):1837-1846.
121. Kawakami K., Kinjo Y., Uezu K., Yara S., Miyagi K., Koguchi Y., et al. Monocyte chemoattractant protein-1-dependent increase of V alpha 14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. Journal of Immunology 2001, 167(11):6525-6532.
122. Kawakami K., Kinjo Y., Yara S., Koguchi Y., Uezu K., Nakayama T., et al. Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Infection and Immunity 2001, 69(1):213-220. 10.1128/IAI.69.1.213-220.2001.
123. Kawakami K., Kinjo Y., Yara S., Uezu K., Koguchi Y., Tohyama M., et al. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis. Infection and Immunity 2001, 69(11):6643-6650. 10.1128/IAI.69.11.6643-6650.2001.
124. Kawakami K., Yamamoto N., Kinjo Y., Miyagi K., Nakasone C., Uezu K., et al. Critical role of Valpha14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. European Journal of Immunology 2003, 33(12):3322-3330. 10.1002/eji.200324254.
125. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Sato H., et al. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proceedings of the National Academy of Sciences of the United States of America 1998, 95(10):5690-5693.
126. Kilic A., Senses Z., Kurekci A.E., Aydogan H., Sener K., Kismet E., et al. Nosocomial outbreak of Sphingomonas paucimobilis bacteremia in a hemato/oncology unit. Japanese Journal of Infectious Diseases 2007, 60(6):394-396.
127. Kim H.S., Chung D.H. IL-9-producing invariant NKT cells protect against DSS-induced colitis in an IL-4-dependent manner. Mucosal Immunology 2013, 6(2):347-357. 10.1038/mi.2012.77.
128. King I.L., Fortier A., Tighe M., Dibble J., Watts G.F., Veerapen N., et al. Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner. Nature Immunology 2012, 13(1):44-50. 10.1038/ni.2172.
129. Kinjo Y., Illarionov P., Vela J.L., Pei B., Girardi E., Li X., et al. Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nature Immunology 2011, 12(10):966-974. 10.1038/ni.2096.
130. Kinjo Y., Kitano N., Kronenberg M. The role of invariant natural killer T cells in microbial immunity. Journal of Infection and Chemotherapy 2013, 19(4):560-570. 10.1007/s10156-013-0638-1.
131. Kinjo Y., Pei B., Bufali S., Raju R., Richardson S.K., Imamura M., et al. Natural Sphingomonas glycolipids vary greatly in their ability to activate natural killer T cells. Chemical Biology 2008, 15(7):654-664. 10.1016/j.chembiol.2008.05.012.
132. Kinjo Y., Tupin E., Wu D., Fujio M., Garcia-Navarro R., Benhnia M.R., et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nature Immunology 2006, 7(9):978-986. 10.1038/ni1380.
133. Kinjo Y., Wu D., Kim G., Xing G.W., Poles M.A., Ho D.D., et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005, 434(7032):520-525. nature03407 [pii]. 10.1038/nature03407.
134. Kita H., Naidenko O.V., Kronenberg M., Ansari A.A., Rogers P., He X.S., et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 2002, 123(4):1031-1043.
135. Kjer-Nielsen L., Patel O., Corbett A.J., Le Nours J., Meehan B., Liu L., et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 2012, nature11605 [pii]. 10.1038/nature11605.
136. Korten S., Anderson R.J., Hannan C.M., Sheu E.G., Sinden R., Gadola S., et al. Invariant Valpha14 chain NKT cells promote Plasmodium berghei circumsporozoite protein-specific gamma interferon- and tumor necrosis factor alpha-producing CD8+ T cells in the liver after poxvirus vaccination of mice. Infection and Immunity 2005, 73(2):849-858. 10.1128/IAI.73.2.849-858.2005.
137. Kovalovsky D., Uche O.U., Eladad S., Hobbs R.M., Yi W., Alonzo E., et al. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nature Immunology 2008, 9(9):1055-1064. 10.1038/ni.1641.
138. Kronenberg M. Toward an understanding of NKT cell biology: Progress and paradoxes. Annual Review of Immunology 2005, 23:877-900. 10.1146/annurev.immunol.23.021704.115742.
139. Kronenberg M. When less is more: T lymphocyte populations with restricted antigen receptor diversity. Journal of Immunology 2014, 193(3):975-976. 10.4049/jimmunol.1401491.
140. Kronenberg M., Gapin L. Natural killer T cells: Know thyself. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(14):5713-5714. 10.1073/pnas.0701493104.
141. Kumar H., Belperron A., Barthold S.W., Bockenstedt L.K. Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. Journal of Immunology 2000, 165(9):4797-4801.
142. Kunsman J.E., Caldwell D.R. Comparison of the sphingolipid content of rumen Bacteroides species. Applied Microbiology 1974, 28(6):1088-1089.
143. Kusters J.G., van Vliet A.H., Kuipers E.J. Pathogenesis of Helicobacter pylori infection. Clinical Microbiology Reviews 2006, 19(3):449-490. 10.1128/CMR.00054-05.
144. Kuylenstierna C., Bjorkstrom N.K., Andersson S.K., Sahlstrom P., Bosnjak L., Paquin-Proulx D., et al. NKG2D performs two functions in invariant NKT cells: Direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d. European Journal of Immunology 2011, 41(7):1913-1923. 10.1002/eji.200940278.
145. Lai Y.G., Hou M.S., Lo A., Huang S.T., Huang Y.W., Yang-Yen H.F., et al. IL-15 modulates the balance between Bcl-2 and Bim via a Jak3/1-PI3K-Akt-ERK pathway to promote CD8alphaalpha+ intestinal intraepithelial lymphocyte survival. European Journal of Immunology 2013, 43(9):2305-2316. 10.1002/eji.201243026.
146. Landwehr-Kenzel S., Henneke P. Interaction of Streptococcus agalactiae and cellular innate immunity in colonization and disease. Frontiers in Immunology 2014, 5:519. 10.3389/fimmu.2014.00519.
147. Lanier L.L., Chang C., Phillips J.H. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. Journal of Immunology 1994, 153(6):2417-2428.
148. Lantz O., Bendelac A. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8-T cells in mice and humans. Journal of Experimental Medicine 1994, 180(3):1097-1106.
149. Lappas C.M., Day Y.J., Marshall M.A., Engelhard V.H., Linden J. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. Journal of Experimental Medicine 2006, 203(12):2639-2648. 10.1084/jem.20061097.
150. Latour S., Gish G., Helgason C.D., Humphries R.K., Pawson T., Veillette A. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product. Nature Immunology 2001, 2(8):681-690. 10.1038/90615.
151. Lawrenczyk A., Kim S., Wen X., Xiong R., Yuan W. Exploring the therapeutic potentials of iNKT cells for anti-HBV treatment. Pathogens 2014, 3(3):563-576. 10.3390/pathogens3030563.
152. Lazarevic V., Zullo A.J., Schweitzer M.N., Staton T.L., Gallo E.M., Crabtree G.R., et al. The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells. Nature Immunology 2009, 10(3):306-313. 10.1038/ni.1696.
153. Le Bourhis L., Martin E., Peguillet I., Guihot A., Froux N., Core M., et al. Antimicrobial activity of mucosal-associated invariant T cells. Nature Immunology 2010, 11(8):701-708. ni.1890 [pii]. 10.1038/ni.1890.
154. Lee Y.J., Holzapfel K.L., Zhu J., Jameson S.C., Hogquist K.A. Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nature Immunology 2013, 14(11):1146-1154. 10.1038/ni.2731.
155. Lee Y.S., Lee K.A., Lee J.Y., Kang M.H., Song Y.C., Baek D.J., et al. An alpha-GalCer analogue with branched acyl chain enhances protective immune responses in a nasal influenza vaccine. Vaccine 2011, 29(3):417-425. 10.1016/j.vaccine.2010.11.005.
156. Lee W.Y., Moriarty T.J., Wong C.H., Zhou H., Strieter R.M., van Rooijen N., et al. An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells. Nature Immunology 2010, 11(4):295-302. 10.1038/ni.1855.
157. Lee W.Y., Sanz M.J., Wong C.H., Hardy P.O., Salman-Dilgimen A., Moriarty T.J., et al. Invariant natural killer T cells act as an extravascular cytotoxic barrier for joint-invading Lyme Borrelia. Proceedings of the National Academy of Sciences of the United States of America 2014, 111(38):13936-13941. 10.1073/pnas.1404769111.
158. Leeansyah E., Ganesh A., Quigley M.F., Sonnerborg A., Andersson J., Hunt P.W., et al. Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood 2013, 121(7):1124-1135. 10.1182/Blood-2012-07-445429.
159. Leeansyah E., Loh L., Nixon D.F., Sandberg J.K. Acquisition of innate-like microbial reactivity in mucosal tissues during human fetal MAIT-cell development. Nature Communications 2014, 5:3143. 10.1038/ncomms4143.
160. Leite-De-Moraes M.C., Hameg A., Arnould A., Machavoine F., Koezuka Y., Schneider E., et al. A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement. Journal of Immunology 1999, 163(11):5871-5876.
161. Levitsky H.I., Golumbek P.T., Pardoll D.M. The fate of CD4-8- T cell receptor-alpha beta+ thymocytes. Journal of Immunology 1991, 146(4):1113-1117.
162. Levy O., Orange J.S., Hibberd P., Steinberg S., LaRussa P., Weinberg A., et al. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells. Journal of Infectious Diseases 2003, 188(7):948-953. 10.1086/378503.
163. Li Y., Girardi E., Wang J., Yu E.D., Painter G.F., Kronenberg M., et al. The Valpha14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode. Journal of Experimental Medicine 2010, 207(11):2383-2393. 10.1084/jem.20101335.
164. Long X., Deng S., Mattner J., Zang Z., Zhou D., McNary N., et al. Synthesis and evaluation of stimulatory properties of Sphingomonadaceae glycolipids. Nature Chemical Biology 2007, 3(9):559-564. 10.1038/nchembio.2007.19.
165. Lopez-Sagaseta J., Sibener L.V., Kung J.E., Gumperz J., Adams E.J. Lysophospholipid presentation by CD1d and recognition by a human natural killer T-cell receptor. EMBO Journal 2012, 31(8):2047-2059. 10.1038/emboj.2012.54.
166. Lotter H., Gonzalez-Roldan N., Lindner B., Winau F., Isibasi A., Moreno-Lafont M., et al. Natural killer T cells activated by a lipopeptidophosphoglycan from Entamoeba histolytica are critically important to control amebic liver abscess. PLoS Pathogen 2009, 5(5):e1000434. 10.1371/journal.ppat.1000434.
167. Lotter H., Jacobs T., Gaworski I., Tannich E. Sexual dimorphism in the control of amebic liver abscess in a mouse model of disease. Infection and Immunity 2006, 74(1):118-124. 10.1128/IAI.74.1.118-124.2006.
168. Lynch L., Michelet X., Zhang S., Brennan P.J., Moseman A., Lester C., et al. Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg) cells and macrophages in adipose tissue. Nature Immunology 2015, 16(1):85-95. 10.1038/ni.3047.
169. Lynch L., O'Shea D., Winter D.C., Geoghegan J., Doherty D.G., O'Farrelly C. Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity. European Journal of Immunology 2009, 39(7):1893-1901. 10.1002/eji.200939349.
170. Mallevaey T., Clarke A.J., Scott-Browne J.P., Young M.H., Roisman L.C., Pellicci D.G., et al. A molecular basis for NKT cell recognition of CD1d-self-antigen. Immunity 2011, 34(3):315-326. 10.1016/j.immuni.2011.01.013.
171. Martin E., Treiner E., Duban L., Guerri L., Laude H., Toly C., et al. Stepwise development of MAIT cells in mouse and human. PLoS Biology 2009, 7(3):e54. 08-PLBI-RA-3994 [pii]. 10.1371/journal.pbio.1000054.
172. Matsuda J.L., Gapin L., Fazilleau N., Warren K., Naidenko O.V., Kronenberg M. Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor beta repertoire and small clone size. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(22):12636-12641. 10.1073/pnas.221445298.
173. Matsuda J.L., Gapin L., Sidobre S., Kieper W.C., Tan J.T., Ceredig R., et al. Homeostasis of V alpha 14i NKT cells. Nature Immunology 2002, 3(10):966-974. 10.1038/ni837.
174. Matsuda J.L., Naidenko O.V., Gapin L., Nakayama T., Taniguchi M., Wang C.R., et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. Journal of Experimental Medicine 2000, 192(5):741-754.
175. Mattner J., Debord K.L., Ismail N., Goff R.D., Cantu C., Zhou D., et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005, 434(7032):525-529. 10.1038/nature03408.
176. McNab F.W., Berzins S.P., Pellicci D.G., Kyparissoudis K., Field K., Smyth M.J., et al. The influence of CD1d in postselection NKT cell maturation and homeostasis. Journal of Immunology 2005, 175(6):3762-3768.
177. Meierovics A., Yankelevich W.J., Cowley S.C. MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection. Proceedings of the National Academy of Sciences of the United States of America 2013, 110(33):E3119-E3128. 10.1073/pnas.1302799110.
178. Michel M.L., Keller A.C., Paget C., Fujio M., Trottein F., Savage P.B., et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. Journal of Experimental Medicine 2007, 204(5):995-1001. 10.1084/jem.20061551.
179. Michel M.L., Mendes-da-Cruz D., Keller A.C., Lochner M., Schneider E., Dy M., et al. Critical role of ROR-gammat in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(50):19845-19850. 10.1073/pnas.0806472105.
180. Miley M.J., Truscott S.M., Yu Y.Y., Gilfillan S., Fremont D.H., Hansen T.H., et al. Biochemical features of the MHC-related protein 1 consistent with an immunological function. Journal of Immunology 2003, 170(12):6090-6098.
181. Minagawa M., Iiai T., Sato Y., Yamamoto S., Hatakeyama K. Repeated administration of alpha-galactosyl ceramide attenuates of natural killer T cells. Gan to Kagaku Ryoho 2005, 32(11):1553-1555.
182. Moll M., Snyder-Cappione J., Spotts G., Hecht F.M., Sandberg J.K., Nixon D.F. Expansion of CD1d-restricted NKT cells in patients with primary HIV-1 infection treated with interleukin-2. Blood 2006, 107(8):3081-3083. 10.1182/blood-2005-09-3636.
183. Morita M., Motoki K., Akimoto K., Natori T., Sakai T., Sawa E., et al. Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice. Journal of Medicinal Chemistry 1995, 38(12):2176-2187.
184. Motsinger A., Haas D.W., Stanic A.K., Van Kaer L., Joyce S., Unutmaz D. CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. Journal of Experimental Medicine 2002, 195(7):869-879.
185. Nagarajan N.A., Kronenberg M. Invariant NKT cells amplify the innate immune response to lipopolysaccharide. Journal of Immunology 2007, 178(5):2706-2713.
186. Nandy S., Dudeja M., Das A.K., Tiwari R. Community acquired bacteremia by Sphingomonas paucimobilis: Two rare case reports. Journal of Clinical and Diagnostic Research 2013, 7(12):2947-2949. 10.7860/JCDR/2013/6459.3802.
187. Natori T., Koezuka Y., Higa T. Agelasphins, novel alpha-galactosylceramides from the marine sponge Agelas mauritianus. Tetrahedron Letters 1993, 34(35):5591-5592. 10.1016/S0040-4039(00)73889-5.
188. Nichols K.E., Hom J., Gong S.Y., Ganguly A., Ma C.S., Cannons J.L., et al. Regulation of NKT cell development by SAP, the protein defective in XLP. Nature Medicine 2005, 11(3):340-345. 10.1038/nm1189.
189. Nieuwenhuis E.E., Matsumoto T., Exley M., Schleipman R.A., Glickman J., Bailey D.T., et al. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nature Medicine 2002, 8(6):588-593. 10.1038/nm0602-588.
190. O'Brien K.L., Wolfson L.J., Watt J.P., Henkle E., Deloria-Knoll M., McCall N., et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: Global estimates. Lancet 2009, 374(9693):893-902. 10.1016/S0140-6736(09)61204-6.
191. Oh-Hora M., Komatsu N., Pishyareh M., Feske S., Hori S., Taniguchi M., et al. Agonist-selected T cell development requires strong T cell receptor signaling and store-operated calcium entry. Immunity 2013, 38(5):881-895. 10.1016/j.immuni.2013.02.008.
192. Olson C.M., Bates T.C., Izadi H., Radolf J.D., Huber S.A., Boyson J.E., et al. Local production of IFN-gamma by invariant NKT cells modulates acute Lyme carditis. Journal of Immunology 2009, 182(6):3728-3734. 10.4049/jimmunol.0804111.
193. Olszak T., An D., Zeissig S., Vera M.P., Richter J., Franke A., et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012, 336(6080):489-493. 10.1126/science.1219328.
194. Orloski K.A., Hayes E.B., Campbell G.L., Dennis D.T. Surveillance for Lyme disease-United States, 1992-1998. MMWR CDC Surveillance Summaries 2000, 49(3):1-11.
195. Padte N.N., Boente-Carrera M., Andrews C.D., McManus J., Grasperge B.F., Gettie A., et al. A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates. PLoS One 2013, 8(10):e78407. 10.1371/journal.pone.0078407.
196. Paget C., Ivanov S., Fontaine J., Renneson J., Blanc F., Pichavant M., et al. Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: Potential role in protection against lung epithelial damages. Journal of Biological Chemistry 2012, 287(12):8816-8829. 10.1074/jbc.M111.304758.
197. Pasquier B., Yin L., Fondaneche M.C., Relouzat F., Bloch-Queyrat C., Lambert N., et al. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. Journal of Experimental Medicine 2005, 201(5):695-701. 10.1084/jem.20042432.
198. Patel O., Pellicci D.G., Uldrich A.P., Sullivan L.C., Bhati M., McKnight M., et al. Vbeta2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(47):19007-19012. 10.1073/pnas.1109066108.
199. Pei B., Speak A.O., Shepherd D., Butters T., Cerundolo V., Platt F.M., et al. Diverse endogenous antigens for mouse NKT cells: Self-antigens that are not glycosphingolipids. Journal of Immunology 2011, 186(3):1348-1360. 10.4049/jimmunol.1001008.
200. Pellicci D.G., Hammond K.J., Uldrich A.P., Baxter A.G., Smyth M.J., Godfrey D.I. A natural killer T (NKT) cell developmental pathway involving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage. Journal of Experimental Medicine 2002, 195(7):835-844.
201. Pellicci D.G., Patel O., Kjer-Nielsen L., Pang S.S., Sullivan L.C., Kyparissoudis K., et al. Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors. Immunity 2009, 31(1):47-59. 10.1016/j.immuni.2009.04.018.
202. Petro C., Gonzalez P.A., Cheshenko N., Jandl T., Khajoueinejad N., Benard A., et al. Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease. Elife 2015, 4. 10.7554/eLife.06054.
203. Porcelli S., Yockey C.E., Brenner M.B., Balk S.P. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. Journal of Experimental Medicine 1993, 178(1):1-16.
204. Porubsky S., Speak A.O., Luckow B., Cerundolo V., Platt F.M., Grone H.J. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(14):5977-5982. 10.1073/pnas.0611139104.
205. Rachitskaya A.V., Hansen A.M., Horai R., Li Z., Villasmil R., Luger D., et al. Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. Journal of Immunology 2008, 180(8):5167-5171.
206. Raftery M.J., Winau F., Kaufmann S.H., Schaible U.E., Schonrich G. CD1 antigen presentation by human dendritic cells as a target for herpes simplex virus immune evasion. Journal of Immunology 2006, 177(9):6207-6214.
207. Raftery M.J., Wolter E., Fillatreau S., Meisel H., Kaufmann S.H., Schonrich G. NKT cells determine titer and subtype profile of virus-specific IgG antibodies during herpes simplex virus Infection. Journal of Immunology 2014, 192(9):4294-4302. 10.4049/jimmunol.1300148.
208. Reantragoon R., Corbett A.J., Sakala I.G., Gherardin N.A., Furness J.B., Chen Z., et al. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. Journal of Experimental Medicine 2013, 210(11):2305-2320. 10.1084/jem.20130958.
209. Reantragoon R., Kjer-Nielsen L., Patel O., Chen Z.J., Illing P.T., Bhati M., et al. Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor. Journal of Experimental Medicine 2012, 209(4):761-774. 10.1084/Jem.20112095.
210. Riegert P., Wanner V., Bahram S. Genomics, isoforms, expression, and phylogeny of the MHC class I-related MR1 gene. Journal of Immunology 1998, 161(8):4066-4077.
211. Rigaud S., Fondaneche M.C., Lambert N., Pasquier B., Mateo V., Soulas P., et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 2006, 444(7115):110-114. 10.1038/nature05257.
212. Rizza V., Tucker A.N., White D.C. Lipids of Bacteroides melaninogenicus. Journal of Bacteriology 1970, 101(1):84-91.
213. Roark J.H., Park S.H., Jayawardena J., Kavita U., Shannon M., Bendelac A. CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. Journal of Immunology 1998, 160(7):3121-3127.
214. Ronet C., Darche S., Leite de Moraes M., Miyake S., Yamamura T., Louis J.A., et al. NKT cells are critical for the initiation of an inflammatory bowel response against Toxoplasma gondii. Journal of Immunology 2005, 175(2):899-908.
215. Ronet C., Mempel M., Thieblemont N., Lehuen A., Kourilsky P., Gachelin G. Role of the complementarity-determining region 3 (CDR3) of the TCR-beta chains associated with the V alpha 14 semi-invariant TCR alpha-chain in the selection of CD4+ NK T Cells. Journal of Immunology 2001, 166(3):1755-1762.
216. Rosen D.B., Bettadapura J., Alsharifi M., Mathew P.A., Warren H.S., Lanier L.L. Cutting edge: Lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor. Journal of Immunology 2005, 175(12):7796-7799.
217. Rossjohn J., Pellicci D.G., Patel O., Gapin L., Godfrey D.I. Recognition of CD1d-restricted antigens by natural killer T cells. Nature Reviews. Immunology 2012, 12(12):845-857. 10.1038/nri3328.
218. Rothchild A.C., Jayaraman P., Nunes-Alves C., Behar S.M. iNKT cell production of GM-CSF controls Mycobacterium tuberculosis. PLoS Pathogen 2014, 10(1):e1003805. 10.1371/journal.ppat.1003805.
219. Sag D., Krause P., Hedrick C.C., Kronenberg M., Wingender G. IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset. Journal of Clinical Investigation 2014, 124(9):3725-3740. 10.1172/JCI72308.
220. Sales-Campos H., Tonani L., Cardoso C.R., Kress M.R. The immune interplay between the host and the pathogen in Aspergillus fumigatus lung infection. BioMed Research International 2013, 2013:693023. 10.1155/2013/693023.
221. Salio M., Silk J.D., Jones E.Y., Cerundolo V. Biology of CD1- and MR1-restricted T cells. Annual Review of Immunology 2014, 32:323-366. 10.1146/annurev-immunol-032713-120243.
222. Savage A.K., Constantinides M.G., Han J., Picard D., Martin E., Li B., et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 2008, 29(3):391-403. 10.1016/j.immuni.2008.07.011.
223. Scanlon S.T., Thomas S.Y., Ferreira C.M., Bai L., Krausz T., Savage P.B., et al. Airborne lipid antigens mobilize resident intravascular NKT cells to induce allergic airway inflammation. Journal of Experimental Medicine 2011, 208(10):2113-2124. 10.1084/jem.20110522.
224. Schroder N.W., Schombel U., Heine H., Gobel U.B., Zahringer U., Schumann R.R. Acylated cholesteryl galactoside as a novel immunogenic motif in Borrelia burgdorferi sensu stricto. Journal of Biological Chemistry 2003, 278(36):33645-33653. 10.1074/jbc.M305799200.
225. Schumann J., Facciotti F., Panza L., Michieletti M., Compostella F., Collmann A., et al. Differential alteration of lipid antigen presentation to NKT cells due to imbalances in lipid metabolism. European Journal of Immunology 2007, 37(6):1431-1441. 10.1002/eji.200737160.
226. Seach N., Guerri L., Le Bourhis L., Mburu Y., Cui Y., Bessoles S., et al. Double-positive thymocytes select mucosal-associated invariant T cells. Journal of Immunology 2013, 191(12):6002-6009. 10.4049/jimmunol.1301212.
227. Seiler M.P., Mathew R., Liszewski M.K., Spooner C.J., Barr K., Meng F., et al. Elevated and sustained expression of the transcription factors Egr1 and Egr2 controls NKT lineage differentiation in response to TCR signaling. Nature Immunology 2012, 13(3):264-271. 10.1038/ni.2230.
228. Selmi C., Balkwill D.L., Invernizzi P., Ansari A.A., Coppel R.L., Podda M., et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 2003, 38(5):1250-1257. 10.1053/jhep.2003.50446.
229. Sidobre S., Naidenko O.V., Sim B.C., Gascoigne N.R., Garcia K.C., Kronenberg M. The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex. Journal of Immunology 2002, 169(3):1340-1348.
230. Smiley S.T., Lanthier P.A., Couper K.N., Szaba F.M., Boyson J.E., Chen W., et al. Exacerbated susceptibility to infection-stimulated immunopathology in CD1d-deficient mice. Journal of Immunology 2005, 174(12):7904-7911.
231. Smithgall M.D., Comeau M.R., Yoon B.R., Kaufman D., Armitage R., Smith D.E. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. International Immunology 2008, 20(8):1019-1030. 10.1093/intimm/dxn060.
232. Speak A.O., Salio M., Neville D.C., Fontaine J., Priestman D.A., Platt N., et al. Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(14):5971-5976. 10.1073/pnas.0607285104.
233. Spits H., Di Santo J.P. The expanding family of innate lymphoid cells: Regulators and effectors of immunity and tissue remodeling. Nature Immunology 2011, 12(1):21-27. 10.1038/ni.1962.
234. Sriram V., Du W., Gervay-Hague J., Brutkiewicz R.R. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. European Journal of Immunology 2005, 35(6):1692-1701. 10.1002/eji.200526157.
235. Steere A.C., Malawista S.E., Snydman D.R., Shope R.E., Andiman W.A., Ross M.R., et al. Lyme arthritis: An epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis and Rheumatism 1977, 20(1):7-17.
236. Stenstrom M., Skold M., Ericsson A., Beaudoin L., Sidobre S., Kronenberg M., et al. Surface receptors identify mouse NK1.1+ T cell subsets distinguished by function and T cell receptor type. European Journal of Immunology 2004, 34(1):56-65. 10.1002/eji.200323963.
237. Sullivan B.A., Nagarajan N.A., Wingender G., Wang J., Scott I., Tsuji M., et al. Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells. Journal of Immunology 2010, 184(1):141-153. 10.4049/jimmunol.0902880.
238. Sykes M. Unusual T cell populations in adult murine bone marrow. Prevalence of CD3+CD4-CD8- and alpha beta TCR+NK1.1+ cells. Journal of Immunology 1990, 145(10):3209-3215.
239. Tatituri R.V., Watts G.F., Bhowruth V., Barton N., Rothchild A., Hsu F.F., et al. Recognition of microbial and mammalian phospholipid antigens by NKT cells with diverse TCRs. Proceedings of the National Academy of Sciences of the United States of America 2013, 110(5):1827-1832. 10.1073/pnas.1220601110.
240. Thomas S.Y., Scanlon S.T., Griewank K.G., Constantinides M.G., Savage A.K., Barr K.A., et al. PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions. Journal of Experimental Medicine 2011, 208(6):1179-1188. 10.1084/jem.20102630.
241. Tilloy F., Treiner E., Park S.H., Garcia C., Lemonnier F., de la Salle H., et al. An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals. Journal of Experimental Medicine 1999, 189(12):1907-1921.
242. Townsend M.J., Weinmann A.S., Matsuda J.L., Salomon R., Farnham P.J., Biron C.A., et al. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 2004, 20(4):477-494.
243. Treiner E., Duban L., Bahram S., Radosavljevic M., Wanner V., Tilloy F., et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 2003, 422(6928):164-169. nature01433 [pii]. 10.1038/nature01433.
244. Triggiani M., Granata F., Balestrieri B., Petraroli A., Scalia G., Del Vecchio L., et al. Secretory phospholipases A2 activate selective functions in human eosinophils. Journal of Immunology 2003, 170(6):3279-3288.
245. Tupin E., Benhnia M.R., Kinjo Y., Patsey R., Lena C.J., Haller M.C., et al. NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(50):19863-19868. 10.1073/pnas.0810519105.
246. Turtle C.J., Delrow J., Joslyn R.C., Swanson H.M., Basom R., Tabellini L., et al. Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161(hi) CD8alpha semi-invariant T cells. Blood 2011, 118(10):2752-2762. blood-2011-02-334698 [pii]. 10.1182/blood-2011-02-334698.
247. Turtle C.J., Swanson H.M., Fujii N., Estey E.H., Riddell S.R. A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy. Immunity 2009, 31(5):834-844. S1074-7613(09)00452-X [pii]. 10.1016/j.immuni.2009.09.015.
248. Tyznik A.J., Tupin E., Nagarajan N.A., Her M.J., Benedict C.A., Kronenberg M. Cutting edge: The mechanism of invariant NKT cell responses to viral danger signals. Journal of Immunology 2008, 181(7):4452-4456.
249. Tyznik A.J., Verma S., Wang Q., Kronenberg M., Benedict C.A. Distinct requirements for activation of NKT and NK cells during viral infection. Journal of Immunology 2014, 192(8):3676-3685. 10.4049/jimmunol.1300837.
250. Ussher J.E., Bilton M., Attwod E., Shadwell J., Richardson R., de Lara C., et al. CD161++ CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner. European Journal of Immunology 2014, 44(1):195-203. 10.1002/eji.201343509.
251. Vahl J.C., Heger K., Knies N., Hein M.Y., Boon L., Yagita H., et al. NKT cell-TCR expression activates conventional T cells in vivo, but is largely dispensable for mature NKT cell biology. PLoS Biology 2013, 11(6):e1001589. 10.1371/journal.pbio.1001589.
252. van Der Vliet H.J., Nishi N., de Gruijl T.D., von Blomberg B.M., van den Eertwegh A.J., Pinedo H.M., et al. Human natural killer T cells acquire a memory-activated phenotype before birth. Blood 2000, 95(7):2440-2442.
253. van der Vliet H.J., van Vonderen M.G., Molling J.W., Bontkes H.J., Reijm M., Reiss P., et al. Cutting edge: Rapid recovery of NKT cells upon institution of highly active antiretroviral therapy for HIV-1 infection. Journal of Immunology 2006, 177(9):5775-5778.
254. van der Vliet H.J., von Blomberg B.M., Hazenberg M.D., Nishi N., Otto S.A., van Benthem B.H., et al. Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection. Journal of Immunology 2002, 168(3):1490-1495.
255. Vasan S., Poles M.A., Horowitz A., Siladji E.E., Markowitz M., Tsuji M. Function of NKT cells, potential anti-HIV effector cells, are improved by beginning HAART during acute HIV-1 infection. International Immunology 2007, 19(8):943-951. 10.1093/intimm/dxm055.
256. Voyle R.B., Beermann F., Lees R.K., Schumann J., Zimmer J., Held W., et al. Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D. Journal of Experimental Medicine 2003, 197(7):919-925. 10.1084/jem.20021615.
257. Walters L.L. Leishmania differentiation in natural and unnatural sand fly hosts. Journal of Eukaryotic Microbiology 1993, 40(2):196-206.
258. Wang X., Bishop K.A., Hegde S., Rodenkirch L.A., Pike J.W., Gumperz J.E. Human invariant natural killer T cells acquire transient innate responsiveness via histone H4 acetylation induced by weak TCR stimulation. Journal of Experimental Medicine 2012, 209(5):987-1000. 10.1084/jem.20111024.
259. Wang J., Li Y., Kinjo Y., Mac T.T., Gibson D., Painter G.F., et al. Lipid binding orientation within CD1d affects recognition of Borrelia burgorferi antigens by NKT cells. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(4):1535-1540. 10.1073/pnas.0909479107.
260. Watarai H., Sekine-Kondo E., Shigeura T., Motomura Y., Yasuda T., Satoh R., et al. Development and function of invariant natural killer T cells producing T(h)2- and T(h)17-cytokines. PLoS Biology 2012, 10(2):e1001255. 10.1371/journal.pbio.1001255.
261. Wei D.G., Lee H., Park S.H., Beaudoin L., Teyton L., Lehuen A., et al. Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes. Journal of Experimental Medicine 2005, 202(2):239-248. 10.1084/jem.20050413.
262. Weinreich M.A., Odumade O.A., Jameson S.C., Hogquist K.A. T cells expressing the transcription factor PLZF regulate the development of memory-like CD8+ T cells. Nature Immunology 2010, 11(8):709-716. 10.1038/ni.1898.
263. Wesley J.D., Tessmer M.S., Chaukos D., Brossay L. NK cell-like behavior of Valpha14i NK T cells during MCMV infection. PLoS Pathogen 2008, 4(7):e1000106. 10.1371/journal.ppat.1000106.
264. Wieland Brown L.C., Penaranda C., Kashyap P.C., Williams B.B., Clardy J., Kronenberg M., et al. Production of alpha-galactosylceramide by a prominent member of the human gut microbiota. PLoS Biology 2013, 11(7):e1001610. 10.1371/journal.pbio.1001610.
265. Wingender G., Hiss M., Engel I., Peukert K., Ley K., Haller H., et al. Neutrophilic granulocytes modulate invariant NKT cell function in mice and humans. Journal of Immunology 2012, 188(7):3000-3008. 10.4049/jimmunol.1101273.
266. Wingender G., Stepniak D., Krebs P., Lin L., McBride S., Wei B., et al. Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice. Gastroenterology 2012, 143(2):418-428. 10.1053/j.gastro.2012.04.017.
267. Wozniak K.L., Olszewski M.A., Wormley F.L. Molecules at the interface of Cryptococcus and the host that determine disease susceptibility. Fungal Genetics and Biology 2014, 10.1016/j.fgb.2014.10.013.
268. Wu D., Zajonc D.M., Fujio M., Sullivan B.A., Kinjo Y., Kronenberg M., et al. Design of natural killer T cell activators: Structure and function of a microbial glycosphingolipid bound to mouse CD1d. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(11):3972-3977. 10.1073/pnas.0600285103.
269. Yanagisawa K., Yue S., van der Vliet H.J., Wang R., Alatrakchi N., Golden-Mason L., et al. Ex vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis C. Journal of Viral Hepatitis 2013, 20(8):556-565. 10.1111/jvh.12081.
270. Young M.H., U'Ren L., Huang S., Mallevaey T., Scott-Browne J., Crawford F., et al. MAIT cell recognition of MR1 on bacterially infected and uninfected cells. PLoS One 2013, 8(1):e53789. 10.1371/journal.pone.0053789.
271. Yuan W., Dasgupta A., Cresswell P. Herpes simplex virus evades natural killer T cell recognition by suppressing CD1d recycling. Nature Immunology 2006, 7(8):835-842. 10.1038/ni1364.
272. Zajonc D.M., Kronenberg M. CD1 mediated T cell recognition of glycolipids. Current Opinion in Structural Biology 2007, 17(5):521-529. 10.1016/j.sbi.2007.09.010.
273. Zamora M.R. DNA viruses (CMV, EBV, and the herpesviruses). Seminars in Respiratory and Critical Care Medicine 2011, 32(4):454-470. 10.1055/s-0031-1283285.
274. Zhou D., Mattner J., Cantu C., Schrantz N., Yin N., Gao Y., et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 2004, 306(5702):1786-1789. 10.1126/science.1103440.
275. Zuppa A., Costantini S., Costantini M. Comparative sequence analysis of bacterial symbionts from the marine sponges Geodia cydonium and Ircinia muscarum. Bioinformation 2014, 10(4):196-200. 10.6026/97320630010196.